99
Participants
Start Date
December 13, 2022
Primary Completion Date
September 25, 2025
Study Completion Date
September 25, 2025
brigimadlin
brigimadlin
National Taiwan University Cancer Center, Taipei
Prince of Wales Hospital-Randwick-66496, Randwick
Edegem - UNIV UZ Antwerpen, Edegem
LK Wiener Neustadt, Wiener Neustadt
University Hospital Bern/Inselspital Bern, Bern
Austin Health, Heidelberg
Ordensklinikum Linz GmbH - Barmherzige Schwestern, Linz
ICON-South Brisbane-69267, South Brisbane
Rainbow Oncology, KwaZulu
Flinders Medical Centre, Bedford Park
UNIV UZ Gent, Ghent
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Memorial Sloan-Kettering Cancer Center, New York
Taipei Veterans General Hospital, Taipei
King Abdul Aziz Medical City, Riyadh
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
University of Pennsylvania, Philadelphia
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, Washington D.C.
CTR Georges-François Leclerc, Dijon
Fundación Jiménez Díaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Medizinische Hochschule Hannover, Hanover
Southern Cancer Center, Mobile
Srinagarind Hospital, Muang
Norton Cancer Institute, Downtown, Louisville
Cleveland Clinic, Cleveland
Hospital Clínico de Valencia, Valencia
University of Michigan Health System, Ann Arbor
Krankenhaus Nordwest, Frankfurt, Frankfurt
Nebraska Cancer Specialists-Omaha-69066, Omaha
The University of Texas MD Anderson Cancer Center, Houston
Rocky Mountain Cancer Centers-Lone Tree-69498, Lone Tree
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Klinikum der Universität München AÖR, München
University of Arizona, Tucson
Universitätsklinikum Ulm, Ulm
Songklanagarind Hospital, Hat Yai
Stanford Cancer Institute, Palo Alto
INS Gustave Roussy, Villejuif
Providence Medical Foundation-Santa Rosa -69764, Santa Rosa
Oregon Health and Sciences University, Portland
Oncology Associates of Oregon, PC, Eugene
National University Hospital-Singapore-42005, Singapore
China Medical University Hospital, Taichung
University of Southern California, Los Angeles
Universitätsklinikum Carl Gustav Carus Dresden, Dresden
National Cancer Center Hospital East, Chiba, Kashiwa
Kanagawa Cancer Center, Kanagawa, Yokohama
Tohoku University Hospital, Miyagi, Sendai
Osaka International Cancer Institute, Osaka, Osaka
National Cancer Center Hospital, Tokyo, Chuo-ku
Japanese Foundation for Cancer Research, Tokyo, Koto-ku
Yamaguchi University Hospital, Yamaguchi, Ube
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital Universitari Vall D Hebron, Barcelona
University Hospital Geneva, Geneva
University College Hospital, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY